Ware Grove
Analyst · CJS Securities. Please go ahead
Thank you, Jerry, and good morning, everyone. I want to take a few minutes to go over the highlights of the numbers we released this morning and talk about what we expect for the full year. The results we reported for the second quarter and first half include the impact of two major nonrecurring items. As required, the reported GAAP numbers fully reflect the impact of those items. But in order to provide greater clarity on the results from continuing operations, we have also presented adjusted numbers to exclude the impact of those items. Jerry talked about the settlement we reached on the UPMC matter and the second quarter charge of $30.5 million that we reported net of insurance coverage. In addition, during the second quarter we divested a small non-core wholesale insurance operation and we recorded a gain of $6.4 million as a result of that transaction. The earnings release includes a reconciliation of those nonrecurring items from the GAAP presentation to arrive at adjusted earnings per share numbers. Of course, we can answer any further questions you may have on these two nonrecurring items during the Q&A period following our comments. But without going into further detail, I will focus my comments here on the adjusted numbers. We think the adjusted numbers are most useful to you as you assess the health and performance of our ongoing business. We are very pleased to report strong growth in total revenue of 17.6% in the second quarter and total revenue growth of 12.6% for the six months ended June 30th. Revenue growth is being driven by a combination of strong same unit growth of 10.5% in the second quarter and same unit growth of 6.8% for the six months. The acquisitions we made last year and through the first half of this year have contributed 7.1% to growth in the second quarter and contributed 5.9% to revenue growth in the six months. The business service lines that were more COVID impacted and reflected declines in 2020 are now recovering and have recorded growth through the first half this year. As we finished 2020, I commented that those businesses represented about 16% of total revenue had collectively declined 12.8% for the full year 2020, compared with 2019. Collectively these businesses recorded growth of 6.7% for the first half this year, which is in line with consolidated first half same unit revenue growth. As evidenced by this very strong first half 6.8% same unit consolidated revenue growth, the core businesses that recorded growth last year in 2020 are continuing to perform very well the first half this year. Acquisitions continue to be an important component of our growth strategy. As a reminder, we announced seven acquisitions last year in 2020 that are expected to contribute $45 million of annualized revenue. Through the first six months this year, we made four additional acquisitions that are expected to contribute $42 million of annualized revenue. The newly acquired businesses are performing very well and we continue to evaluate a number of potential acquisitions with an active pipeline under review. Total revenue in our Financial Services group increased by 21.1% in the second quarter with same unit revenue up by 13.3% compared with a year ago. For the six months, total revenue grew by 14.0% with same unit revenue up by 8.5%. Turning to the Benefits and Insurance group. In the second quarter, total revenue grew by 11.7% with same unit revenue up by 5.3%. For the six months, total revenue within benefits and insurance grew by 10.6% with same unit revenue up by 3.4%. The revenue growth recorded this year has been fueled by the tools and investments we have made in recent years. There have been significant investments to build stronger producer teams. We have developed tools to optimize profitability of client engagements within financial services. Plus our focus on digital marketing efforts is resulting in a stronger pipeline of potential new business. And importantly, we have focused resources to boost acquisition activity. All of these initiatives are gaining traction and represent a concerted effort to enhance revenue growth, while achieving operating leverage to improve margin over time. Eliminating the two nonrecurring items, pre-tax income margin was 12.7% in the second quarter, up 90 basis points compared with 11.8%, a year ago. For the six months, pre-tax income margin was 17.5% up 230 basis points compared with 15.2% a year ago. With early seasonal tax work this year compared with last year, we experienced tailwinds in the first half this year. The second half of the year is seasonally more heavily reliant on project work. The business is performing very well, but second half revenue growth may be less certain. A lower cost structure in the first half this year continues to reflect lessons learned from our experience with the pandemic and that is reflected in higher first half margins. As I commented at the end of the first quarter, we are selectively restoring discretionary items that may present some headwinds and margin pressure in the second half of the year. As we begin to get back in front of clients and prospects, related T&E expense may begin to increase from current extraordinarily low levels. With marketing costs after suspending all programs a year ago, we elected to conduct a second quarter media campaign this year and we are considering a second campaign later in the year. Within our benefits costs, healthcare costs have continued to be lower than expected through the first half this year. Healthcare benefit costs are not highly controllable in the short run and we are expecting second half headwinds as medical visits and elective procedures are beginning to resume in a more normal level of activity after seeing low levels in 2020 that have continued through the first half of 2021. Eliminating the impact of nonrecurring items, we are pleased to report adjusted earnings per share of $0.50 for second quarter, up 28.2% compared with $0.39 compared a year ago. For the six months, adjusted earnings per share, was $1.43 up 36.2% compared with $1.05 reported a year ago. Cash flow and liquidity continue to be strong. At June 30 this year, there was $163.3 million outstanding on our $400 million credit facility. This results in a leverage measure of 1.0 times EBITDA at June 30 with approximately $230 million of unused capacity. After giving effect to the upcoming payment for the UPMC settlement amount, leverage will increase to approximately 1.25 times EBITDA with slightly over $200 million of remaining unused capacity. During the first six months this year, we closed four new acquisitions and used $51.2 million for acquisitions including earn-out payments for acquisitions closed in previous years. We also actively repurchased shares in the open market and we used $63.4 million to repurchase approximately two million shares through June 30. With respect to future earn-out payment obligations, we estimate approximately $5.5 million over the balance of this year approximately $20.8 million in 2022 approximately $14.4 million the following year in 2023 and $17.7 million in 2024 with another approximately $800,000 in 2025. The strong cash flow and a strong balance sheet we have ample flexibility to strategically deploy capital to actively pursue acquisitions and conduct share repurchases. Looking back 18 months during this challenging time period from January of 2020 through today or through June 30 of this year we have closed 11 acquisitions using approximately $140 million of cash for acquisition purposes. Over the same 18-month time period we've also used approximately $120 million to repurchase 4.3 million shares, which is nearly 8% of shares outstanding. Capital spending. The first six months this year was $3.3 million with $2.1 million in the second quarter. This is lower than in recent years and reflects the intentional deferral of spending for facility-related decisions in 2020. In a normal year, we expect capital spending of approximately $12 million. But for 2021 we expect capital spending will come in at approximately $8 million. Day sales outstanding on receivables continue to reflect improvement. At June 30, this year day sales outstanding stood at 84 days compared with 87 days at June 30, a year ago. With a diverse set of clients and no concentration in industries such as hospitality, entertainment or travel that may have higher risk attributes our receivables have continued to perform well. You may recall we recorded a $2 million provision for bad debt in the first quarter a year ago with bad debt expense for the first half a year ago at 62 basis points of revenue. Bad debt expense for the first six months this year is only five basis points. Adjusted EBITDA for the first six months this year was $116.2 million or 20.1% of revenue. This represents a 25% increase over $92.9 million in the first six months a year ago. For the first six months this year, the effective tax rate was 24.01%. Looking to the full-year of 2021, there are a number of unpredictable factors that can impact the effective tax rate either up or down and we expect to continue -- we continue to expect a full-year effective tax rate of approximately 25%. With the share repurchase activity to date through the first half we expect full-year 2021 weighted average fully diluted share count to be approximately 54 million shares. As a result of first half acquisition activity, we are raising our full-year revenue guidance and we now expect total revenue growth in a range of 10% to 12% over the prior year and that this is up from 8% to 10% growth previously. First half growth, in adjusted earnings per share reflects the fact that the business is very healthy. As we set full-year expectations for adjusted earnings per share, we are weighing the uncertain potential to incur higher benefit health care costs in the second half coupled with our desire to selectively restore some level of marketing or other client-related activities designed to enhance revenue growth over time. For those reasons the level of margin improvement achieved in the first half this year is likely not sustainable for the balance of the year. We also need to be prudently cognizant of the continuing potential volatility and uncertainty in the environment. At this point, we expect full-year 2021 adjusted earnings per share, to grow near the higher end of a range of 12% to 15% over the $1.42 EPS reported for 2020. Of course, we will have an opportunity to revisit this guidance at the end of the third quarter. So with these comments I will conclude, and I'll turn it back over to Jerry.